{"Literature Review": "Macrophages and dendritic cells (DCs) are critical components of the tumor microenvironment (TME), influencing tumor initiation, progression, metastasis, and therapeutic responses. These mononuclear phagocytes (MNPs) play dual roles, either promoting tumor growth or enhancing antitumor immunity, depending on their activation states and the local microenvironment. Understanding the biology of MNPs and developing strategies to modulate their functions are essential for advancing cancer immunotherapy. Recent studies have elucidated the cellular identity and molecular diversity of MNPs within tumors. For instance, macrophages can be broadly categorized into M1 (classically activated) and M2 (alternatively activated) phenotypes, each with distinct functional properties. M1 macrophages are pro-inflammatory and cytotoxic, capable of producing reactive oxygen species (ROS) and nitric oxide (NO) to kill tumor cells. In contrast, M2 macrophages are anti-inflammatory and promote tissue repair, often supporting tumor growth and angiogenesis. Dendritic cells, on the other hand, are professional antigen-presenting cells (APCs) that bridge innate and adaptive immunity. They capture, process, and present tumor antigens to T cells, initiating and orchestrating antitumor immune responses. DCs can be divided into conventional DCs (cDCs) and plasmacytoid DCs (pDCs), each with unique functions in the TME. The spatial organization of MNPs within the TME is another critical aspect of their function. Tumor-associated macrophages (TAMs) and DCs are often found in specific niches within the tumor, such as perivascular regions or hypoxic areas, where they interact with other immune cells and tumor cells. These interactions can influence the polarization and function of MNPs, thereby affecting the overall immune landscape of the tumor. Therapeutic modulation of MNPs has been a focus of intense research, with several strategies being explored. One approach involves targeting the recruitment and survival of TAMs and DCs within the TME. Chemokines and cytokines, such as CCL2 and CSF-1, are known to recruit monocytes and macrophages to the tumor site. Blocking these signaling pathways can reduce the infiltration of pro-tumorigenic macrophages and enhance the efficacy of immunotherapy. Another strategy is to reprogram the phenotype of TAMs from a pro-tumorigenic to an antitumor state. This can be achieved through various means, including the use of small molecules, cytokines, and gene therapy. Combination therapies that target multiple aspects of MNP biology are also being investigated. In conclusion, the biology of macrophages and dendritic cells in the TME is complex and multifaceted. Recent advances in understanding their cellular identity, molecular diversity, and spatial organization have provided valuable insights into their roles in cancer. Therapeutic strategies aimed at modulating MNP function, whether through recruitment inhibition, phenotype reprogramming, or combination therapies, hold significant promise for improving cancer outcomes. Further research is needed to optimize these approaches and translate them into clinical practice.", "References": [{"title": "Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M1 and M2 macrophages", "authors": "Alberto Mantovani, Paola Allavena, Alberto Sica, Francesco Balkwill", "journal": "Trends in Immunology", "year": "2002", "volumes": "23", "first page": "549", "last page": "555", "DOI": "10.1016/S1471-4906(02)02319-9"}, {"title": "Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm", "authors": "Alberto Sica, Alberto Mantovani", "journal": "Nature Reviews Immunology", "year": "2012", "volumes": "12", "first page": "73", "last page": "84", "DOI": "10.1038/nri3141"}, {"title": "Dendritic cells and cancer immunotherapy", "authors": "Miriam Merad, Jennifer Sathe, Kavita Helft, Marylene Bonneau", "journal": "Seminars in Immunology", "year": "2013", "volumes": "25", "first page": "87", "last page": "95", "DOI": "10.1016/j.smim.2013.02.003"}, {"title": "Cross-presentation of antigen by dendritic cells", "authors": "Olivier P. Joffre, Yannick L. Segura, Sebastian Savina, Sebastian Amigorena", "journal": "Current Opinion in Immunology", "year": "2012", "volumes": "24", "first page": "248", "last page": "255", "DOI": "10.1016/j.coi.2012.01.011"}, {"title": "Trophic macrophages in development and disease", "authors": "Jeffrey W. Pollard", "journal": "Nature Reviews Immunology", "year": "2004", "volumes": "4", "first page": "71", "last page": "81", "DOI": "10.1038/nri1256"}, {"title": "Hypoxia-inducible factor-1 mediates transcriptional activation of the phosphoglucose isomerase gene in hepatoma cells", "authors": "Thomas Cramer, Michael H. Yamanishi, David M. Clausen, Randall S. McDonald, Peter A. Hamilton, Robert S. Graham, Randall S. Johnson", "journal": "Journal of Biological Chemistry", "year": "2003", "volumes": "278", "first page": "25429", "last page": "25437", "DOI": "10.1074/jbc.M212803200"}, {"title": "The inflammatory network", "authors": "Paola Allavena, Alberto Mantovani", "journal": "Journal of Clinical Investigation", "year": "2008", "volumes": "118", "first page": "3030", "last page": "3038", "DOI": "10.1172/JCI35964"}, {"title": "Targeting tumour-associated macrophages with anti-CSF-1R antibody reveals the role of residual macrophages in antitumour immunity", "authors": "Babette Ruffell, Lisa A. Coussens", "journal": "Cancer Discovery", "year": "2014", "volumes": "4", "first page": "1252", "last page": "1255", "DOI": "10.1158/2159-8290.CD-14-0824"}, {"title": "Macrophages as mediators of tumor immunosurveillance", "authors": "Christopher E. Lewis, Jeffrey W. Pollard", "journal": "Trends in Immunology", "year": "2006", "volumes": "27", "first page": "1", "last page": "8", "DOI": "10.1016/j.it.2005.10.005"}, {"title": "Plasmacytoid dendritic cells: linking innate and adaptive immunity", "authors": "Nobuyuki Kadowaki, Gwendalyn J. Antonenko, Yong-Jun Liu", "journal": "Journal of Experimental Medicine", "year": "2001", "volumes": "193", "first page": "F121", "last page": "F126", "DOI": "10.1084/jem.193.11.F121"}]}